GENB Generate Biomedicines leadership flags accelerated AI drug pipeline advancement as top priority in latest quarterly earnings update CL Colgate edges past Q4 2025 EPS estimates shares climb 11 percent on positive investor sentiment The Cigna Group CI Favorable Earnings Beat Odds Amid Diversified Healthcare Segment Strength Ahead of Q1 2026 Results